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OBJECTIVE: We analyzed the association of LBBB and RBBB with early (defined as the period of 90 days post-discharge)
rehospitalization and all-cause mortality, and all-cause long-term mortality in HF patients.
BACKGROUND: Although it has been reported that QRS prolongation ≥ 120 msec, in heart failure (HF) patients, is associated with increased
all-cause mortality1,2,3 and even sudden death1, there is conflicting data regarding its direct impact on mortality. Ventricular dyssynchrony as
an effect of anomalous conduction could justify the adverse outcome in the case of left bundle branch block (LBBB)1; while patients with QRS
≥ 120 msec with right bundle branch block (RBBB) morphology frequently have more severe bi-ventricular dysfunction4.
PARTNERSHIPS 
 
 
 
 
 
 
 
 
 
 
 
N=65 HF patients
Mean age: 79.2 (SD 10.8)
Median follow-up  13.7 months
Q1: 6.7 to Q3: 18.9]
RESULTS
Characteristics Patients (n=65)
Age, mean (SD) 79.2 ± 10.8
Female Gender, n (%) 37 (56.9)
Hypertension, n (%) 58 (89.2)
Type 2 Diabetes, n (%) 25 (38.5)
Dyslipidemia, n (%) 41 (63.1)
Obesity, n (%) 17 (26.2)
Atrial Fibrillation, n (%) 28 (43.1)
Family History of CVD, n (%) 31 (47.7)
Tabagism, n (%) 21 (32.3)
Chronic Kidney Disease, n (%) 34 (52.3)
GFR (Baseline), median 57.8 (43.8 - 82.2)
GFR (Admission), median 47.9 (33.2 - 68.1)
Previous Acute Myocardial Infarction, n (%) 27 (41.5)
Hypertensive Cardiomyopathy, n (%) 44 (67.7)
Ischemic Cardiomyopathy, n (%) 22 (33.8)
Valvular Cardiomyopathy, n (%) 56 (86.2)
LVEF, mean (SD) 50.38 ± 19.07
NYHA class III, n (%) 43 (66.2)
ACE Inhibitor, n (%) 43 (66.2)
Beta Blocker, n (%) 38 (58.5)
Mineralocorticoid Receptor Antagonists, n (%) 19 (29.2)
Angiotensin II Receptor Blocker, n (%) 11 (16.9)
Loop Diuretic, n (%) 54 (83.1)
Digoxin, n (%) 8 (12.3)
LBBB 14 (21.5%)
RBBB 5 (7.7%)
Values are median (IQR), n (%), or mean ± SD. 
IQR: interquartile range and minimum/maximum, SD: standard deviation, CVD: cardiovascular disease, GFR: glomerular
filtration rate; left bundle branch block (LBBB); right bundle branch block (RBBB).
METHODS: Bundle branch block was assessed in adult patients admitted, to an Internal Medicine ward, with acute decompensated heart
failure in class III or IV of New York Heart Association (NYHA). Subgroup analysis was performed according to the left ventricular ejection
fraction (LVEF) in light of the current European Society of Cardiology guidelines. Descriptive analysis was performed using t test or Wilcoxon
Rank test as applicable. Categorical variables were compared using chi-squared test or Fisher’s Exact test as applicable. Univariate Cox
proportional hazard model was used to evaluate the relationship between variables and outcomes.
CONCLUSION:
- In our study LBBB was a marker of short-term mortality risk in the overall population study.
- Regarding long-term survival, LBBB was also a predictor of worse outcome in the HFrEF subgroup.
- We were, also, able to detect a link between RBBB and early HF readmission in the general population study.
- Our findings suggest that bundle branch block implicates a worse outcome in HF patients, prompt recognition of this high-risk group could help
to offer tailored treatment in order to improve prognosis.
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• In our study the percentage of LBBB (21.5%) was close to the available data1,2, while 
RBBB was present in 7.7% of the patients.
Characteristic
LBBB
HFrEF/LBBB
HR 95% CI P value
3.44 1.05-11.3 0.041
4.14 1.02-16.8 0.047
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LBBB, left bundle branch block ; HR, Hazard ratio.
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• Descriptive analysis showed that only 4.7% of the non-early readmitted patients
presented RBBB versus 13.6% in the early readmitted patients (P-value=0.049).
